Disease Markers / 2017 / Article / Tab 3

Research Article

The Expression and Related Clinical Significance of SIRT3 in Non-Small-Cell Lung Cancer

Table 3

Univariate analysis of the correlation between clinical indicators/SIRT3 expression and prognosis.

Clinical indicatorN5-year survival rate (%)Chi-squareLog-rank test ()

SIRT3 expression level
 Low5487.020.5250.000
 Medium6656.1
 High1127.3
Sex
 Male7364.40.8000.371
 Female5869.0
Age
 ≥608065.00.5150.473
 <605168.6
Pathological type
 SCC3956.42.7910.095
 ACA9270.7
Tumor size
 ≤24983.710.9720.004
 2-34160.5
 ≥34151.3
Tumor site
 Left lung5267.10.3640.546
 Right lung7965.4
Lymphatic metastasis
 Yes3941.028.1880.000
 No9277.2
Pleural invasion
 Yes4170.70.2020.653
 No9064.4
Degree of differentiation
 Low3650.010.9520.004
 Medium6272.6
 High3372.7
Clinical stage
 01110016.0920.001
 I4575.6
 II5362.3
 III2240.9

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.